Retrospective Study
Copyright ©The Author(s) 2018.
World J Hepatol. Jan 27, 2018; 10(1): 82-87
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.82
Table 2 Multivariate analysis of factors predicting liver cirrhosis
Odds ratioP-value95%CI
MPV/PLT ratio≥ 0.71, n = 1513.71< 0.00011.94-7.28
< 0.71, n = 151
PT, %≥ 89.0, n = 1512.680.00181.44-5.06
< 89.0, n = 151
AST, IU/L≥ 39, n = 1553.300.011.30-9.09
< 39, n = 147
ALT, IU/L≥ 34, n = 1532.570.041.02-7.09
< 34, n = 149
Total-bilirubin, mg/dL≥ 0.7, n = 1771.890.041.00-3.61
< 0.7, n = 125
Albumin, g/dL≥ 3.8, n = 1680.950.890.47-1.89
< 3.8, n = 134
Cholinesterase, IU/L≥ 211, n = 1520.980.960.48-1.98
< 211, n = 150
Type 4 collagen, ng/mL≥ 6.5, n = 1660.950.860.51-1.72
< 6.5, n = 136
Hyaluronic acid, ng/mL≥ 124, n = 1532.280.0081.23-4.26
< 124, n = 149
ICGR15, %≥ 14.3, n = 1511.400.300.72-2.68
< 14.3, n = 151
GSA Rmax, mg/min≥ 0.555, n = 1511.510.240.75-3.04
< 0.555, n = 151